Department of Microbiology, Institut Pasteur, 75015 Paris, France.
Department of Biology, San Diego State University, San Diego, CA 92182, USA.
Viruses. 2020 Jul 8;12(7):737. doi: 10.3390/v12070737.
Enteropathogenic (EPEC) is a major pathogen for diarrheal diseases among children. Antibiotics, when used appropriately, are effective; however, their overuse and misuse have led to the rise of antibiotic resistance worldwide. Thus, there are renewed efforts into the development of phage therapy as an alternative antibacterial therapy. Because EPEC in vivo models have shortcomings, a surrogate is used to study the mouse pathogen in animal models. In this study, two new phages CrRp3 and CrRp10, which infect were isolated and characterized. CrRp3 was found to be a new species within the genus and CrRp10 is a new strain within the species , in the genus Both phages appear to have independently evolved from phages, rather than other Citrobacter spp. phages. Neither phage strain carries known genes associated with bacterial virulence, antibiotic resistance, or lysogeny. CrRp3 is more potent, having a 24-fold faster adsorption rate and shorter lytic cycle when compared to the same properties of CrRp10. However, a lysis curve analysis revealed that CrRp10 prevented growth of for 18 h, whereas resistance developed against CrRp3 within 9 h. We also show that hypoxic (5% oxygen) conditions decreased CrRp3 ability to control bacterial densities in culture. In contrast, low oxygen conditions did not affect CrRp10 ability to replicate on . Together, CrRp10 is likely to be the better candidate for future phage therapy investigations.
肠致病性大肠杆菌(EPEC)是导致儿童腹泻病的主要病原体之一。抗生素在适当使用时是有效的;然而,抗生素的过度和滥用导致了全球范围内抗生素耐药性的上升。因此,人们重新努力开发噬菌体疗法作为一种替代抗菌疗法。由于 EPEC 的体内模型存在缺陷,因此使用替代物来研究动物模型中的小鼠病原体。在这项研究中,分离和鉴定了两种新的噬菌体 CrRp3 和 CrRp10,它们感染了。CrRp3 被发现是一个新的种属内的物种,而 CrRp10 是一个新的种属内的菌株,在属内。两种噬菌体似乎都是独立地从大肠杆菌噬菌体进化而来的,而不是其他柠檬酸杆菌属噬菌体。这两种噬菌体株都不携带与细菌毒力、抗生素耐药性或溶原性相关的已知基因。CrRp3 的吸附率更快,裂解周期更短,与 CrRp10 的相同特性相比,吸附率快 24 倍,裂解周期更短。然而,裂解曲线分析表明,CrRp10 阻止了大肠杆菌的生长长达 18 小时,而对 CrRp3 的抗性在 9 小时内就发展起来了。我们还表明,低氧(5%氧气)条件降低了 CrRp3 控制培养物中细菌密度的能力。相比之下,低氧条件并不影响 CrRp10 在大肠杆菌上的复制能力。总的来说,CrRp10 可能是未来噬菌体治疗研究的更好候选者。